DUBLIN, June 20, 2023 /PRNewswire/ — The “Hematologic Malignancies Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027” report has been added to ResearchAndMarkets.com’s offering.
The global hematologic malignancies testing market is anticipated to observe impressive growth during the forecast period 2023-2027
The major factors, including growing occurrences of blood cancer and extensive development in technology, are fueling the growth of the market. Hematologic malignancies are cancers that affect the blood, bone marrow, and lymph nodes. Leukemia, lymphoma, and myeloma are the common types of blood cancer. Hematologic malignancies testing is a medical testing method that helps to diagnose blood cancer.
The other factors supporting the market’s growth are a rise in R&D activities, increasing favorable government funding, rising emphasis on personalized medicine, increasing awareness among patients and healthcare professionals, rise in aging population base, growing adoption of inorganic growth strategies, an increasing number of product launches, and immense potential for emerging submarkets.
Increasing Occurrence of Blood-Related Disorders
The growing incidences of blood-related disorders, such as leukemia, lymphoma, and myeloma, are bolstering the growth of the market globally.
According to the American Cancer Society, in the United States, around every 3 minutes, a person is diagnosed with leukemia, lymphoma, and myeloma. Owing to the rise in the number of patients who have hematologic cancer, the surge in the need for early detection and treatment of blood cancers is augmenting the growth of the market.
Blood cancers are the fifth most common malignancy across the world and the second primary reason for cancer death. For instance, more than 300,000 people are diagnosed yearly with leukemia and 400,000 with lymphoma across the globe.
Technological Advancements and Rise in R&D Activities
The evolution of new technologies in the healthcare sector is surging the growth of the market. The increasing adoption of new innovative technologies, such as digital PCR, next-generation sequencing, cytogenetics, and others, is strengthening the growth of the market.
The developments are helping to minimize the cost and time of treatment and improve the quality of human life. Moreover, the rise in R&D activities is propelling the growth of the market.
Increasing Adoption of Inorganic Growth Strategies
Growing inorganic growth strategies such as mergers, acquisitions, collaborations, partnerships, and an increasing number of product launches by market players are bolstering the growth of the market.
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Hematologic Malignancies Testing Market
- Abbott Laboratories, Inc.
- Asuragen Inc.
- Bio-Rad Laboratories, Inc.
- Adaptive Biotechnologies Corporation
- F.Hoffmann-La-Roche AG
- Illumina, Inc.
- ICON plc.
- Invitae Corporation
- Laboratory Corporation of America Holdings
- Invivoscribe, Inc.
Report Scope:
Hematologic Malignancies Testing Market, By Component:
- Kits
- Gene Panels
- Molecular Clonality Testing
- Translocation Testing
- Mutation Testing
- Others
- Services
Hematologic Malignancies Testing Market, By Component:
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In-Situ Hybridization (FISH)
- Immunohistochemistry (IHC)
- Others
Hematologic Malignancies Testing Market, By Therapeutic Indication:
- Leukemia
- Lymphoma
- Multiple Myeloma
- Myeloproliferative Neoplasms
- Others
Hematologic Malignancies Testing Market, By End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
Hematologic Malignancies Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Turkey
For more information about this report visit https://www.researchandmarkets.com/r/3zdz3s
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
